普萘洛尔联合局部硬化治疗≤5个月儿童大型血管瘤的临床疗效及并发症研究

doi:10.3877/cma.j.issn.2095-5782.2017.04.004

目的：

研究口服普萘洛尔联合局部硬化治疗儿童大型血管瘤的临床疗效以及并发症发生情况。

方法：

选取2013年1月—2016年4月我院收治的年龄≤5个月的大型血管瘤患儿237例，分为两组。单纯治疗组86例采用单纯局部硬化治疗：在DSA或B超引导下，对瘤体采用多点穿刺，回抽见血后，将硬化剂缓慢注入瘤体组织中，至瘤体肿胀或变苍白为度。联合治疗组151例，口服普萘洛尔联合局部硬化治疗：24 h长程心电图正常后第2天始给予普萘洛尔口服，同时行局部硬化治疗，随访3个月~1.5年后，比较两组临床疗效及并发症的发生情况。

结果：

联合治疗组的总有效率96.7%（146/151）高于单纯治疗组89.5%（77/86），差异有统计学意义（χ²=5.045，P<0.05）。且联合治疗组的治愈率71.5%（108/151）也高于单纯治疗组47.7%（41/86），差异有统计学意义（χ²=13.350，P<0.01）。联合治疗组的并发症发生率25.8%（39/151）低于单纯治疗组38.4%（33/86），差异有统计学意义（χ²=4.077，P<0.05）。

结论：

口服普萘洛尔联合局部硬化治疗在有效率上明显优于单纯局部硬化治疗，且并发症少。

关键词: 普萘洛尔, 局部硬化治疗, 临床疗效, 并发症

Objective:

To study the clinical efficacy and occurrence of complication of oral propranolol combined with local sclerotherapy for the treatment of large hemangioma in children.

Methods:

Totally 237 infants (≤ 5 months old) with large hemangioma in Wuhan Children’s Hospital from January 2013 to April 2016 were selected and divided into two groups. The patients in simple treatment group (86 cases) were given local sclerosis treatment. Procedures were as follows: under the guidance of DSA or B ultrasound, multi-point puncture was performed on the tumor, after withdrawing blood, the sclerotherapy agent was slowly injected into the tumor tissue. The patients in combined treatment group (151 cases) were orally given propranolol combined with local sclerotherapy after 24 h long-term ECG is normal. 237 cases were followed up for 3 months to 1.5 years, and the clinical efficacy and complications in two groups were compared.

Results:

The total effective rate in combined treatment group was 96.7% (146/151) , which was higher than that of simple treatment group (89.5%, 77/86) , with significant difference (χ²=5.045, P<0.05) . The cure rate of combined treatment group was 71.5% (108/151) , which was higher than that of simple treatment group (47.7%, 41/86) , with significant difference (χ²=13.350, P<0.01) . The incidence of complications in combined treatment group was 25.8%, which was lower than that of the simple treatment group (38.4%) , with significant difference (χ²=4.077, P<0.05) .

Conclusion:

Oral propranolol combined with local sclerotherapy is significantly better than the local sclerotherapy, with less comparison.

Key words: Propranolol, Local sclerotherapy, Clinical efficacy, Complications

表1 2组的临床疗效比较　例（%）

组别	例数	治愈	显效	有效	无效	总有效(%)
单纯治疗组	86	41(47.7)	25(29.1)	11(12.8)	9(10.5)	77(89.5)
联合治疗组	151	108(71.5)	28(18.5)	10(6.6)	5(3.3)	146(96.7)
χ²值	?	?	?	?	?	5.045
P值	?	?	?	?	?	0.025

表1 2组的临床疗效比较　例（%）

组别	例数	治愈	显效	有效	无效	总有效(%)
单纯治疗组	86	41(47.7)	25(29.1)	11(12.8)	9(10.5)	77(89.5)
联合治疗组	151	108(71.5)	28(18.5)	10(6.6)	5(3.3)	146(96.7)
χ²值	?	?	?	?	?	5.045
P值	?	?	?	?	?	0.025

图1 典型病例1（女，3月，右前臂血管瘤）治疗前后效果图

图2 典型病例2（男，3月，右背部皮肤及皮下组织血管瘤）治疗前后效果图

图3 治疗后不同时间的效果比较

表2 两组并发症发生情况比较　例（%）

组别	例数	发热	胃肠道反应	局部肿胀	溃疡坏死	组织凹陷	合计
单纯治疗组	86	5(5.8)	7(8.1)	16(18.6)	3(3.5)	2(2.3)	33(38.4)
联合治疗组	151	6(4.0)	9(6.0)	18(11.9)	5(3.3)	1(0.7)	39(25.8)
χ²值	?	?	?	?	?	?	4.077
P值	?	?	?	?	?	?	0.043

表2 两组并发症发生情况比较　例（%）

组别	例数	发热	胃肠道反应	局部肿胀	溃疡坏死	组织凹陷	合计
单纯治疗组	86	5(5.8)	7(8.1)	16(18.6)	3(3.5)	2(2.3)	33(38.4)
联合治疗组	151	6(4.0)	9(6.0)	18(11.9)	5(3.3)	1(0.7)	39(25.8)
χ²值	?	?	?	?	?	?	4.077
P值	?	?	?	?	?	?	0.043

1	Frieden IJ, Haggstrom A, Drolet BA, et a1. Infantile hemangiomas: current knowledge, future directions: proceedings of a research workshop on infantile hemangiomas[J]. Pediatr Dermatol，2005，22(5):383-406.
2	Finn MC, Glowacki J, Mulliken JB, et al. Congenital vascular lesions: clinical application of a new classification[J]. J Pediatr Surg，1983，18(6):894-900.
3	Baharudin A, Samsudin AR, Halim AS,et al.Surgical management of a massive facial hemangioma[J]. Med J Malaysia, 2007,62(3):254-255.
4	Komiyama M, Nakajima H, Kitano S，et al. Endovascular treatment of huge cervicofacial hemangioma complicated by Kasabach-Merritt syndrome[J]. Pediatr Neurosurg，2000，33(1):26-30.
5	中华口腔医学会口腔颌面外科专业委员会脉管性疾病学组.口腔颌面部血管瘤及脉管畸形的诊断和治疗指南（草案）[J].中华口腔医学杂志，2005,40(3):185-186.
6	Léauté-Labrèze C, Dumas de la Roque E, et al. Propranolol for severe hemangiomas of infancy [J]. N Engl J Med, 2008, 358(24):2649-2651.
7	Jadhav VM, Tolat SN. Dramatic response of propranolol in hemangioma: report of two cases[J]. Indian J Dermatol Venereol Leprol, 2010, 76(6):691-694.doi: 10.4103/0378-6323.72472.
8	Holmes WJ, Mishra A, Gorst C, et a1. Propranolol as firstline treatment for rapidly proliferating Infantile Haemangiomas[J]. J Plast Reconstr Aesthet surg, 2011, 64(4):445-451.
9	许熠铭，谢民强，刘贤,等.颈部囊性淋巴管瘤患者术后疗效观察[J].临床耳鼻咽喉头颈外科杂志,2010,24(9):400-402.
10	赵丽君，杜玉杰，刘爽，等.三种镇痛方法在人工流产术中的应用比较[J].中国煤炭工业医学杂志，2006, 19(7):2495-2497.
11	Gelmetti C, Frasin A, Restano L. Innovative therapeutics in pediatric dermatology[J]. Dermatol Clin, 2010, 28(3):619-629. doi: 10.1016/j.det.2010.03.005.
12	Lawley L, Siegfried E. Propranolol treatment for hemangiomas of infancy：risks and recommendations[J]. Pediatr Dermatol，2009，26(5):610-614.
13	Haider KM, Plager DA, Neely DE, et al. Outpatient treatment of periocular infantile hemangiomas with oral propranolol[J]. JAAPOS, 2010,14(3):251-256.
14	Rosbe KW, Suh KY, Meyer AK, et al. Propranolol in the management of infantile hemangiomas[J].Arch Otolaryngol Head Neck Surg,2010, 136(7):658-665. doi: 10.1001/archoto.2010.92.
15	Tan ST, ltinteang T, Leadbitter P. Low-dose propranolol for infantile haemangioma[J]. J Plast Reconstr Aestheti Surg, 2011, 64(3):292-299.
16	Moniotte S, Bataille AC, Clapuyt P，et al. Propranolol for Hemangioma of Infancy durmion of treatment. The 18h International Workshop on Vascular Anomalies，Brussels.2010：21-24.
17	Mousa W, Kues K, Haas E，et al. Successful treatment of a large hemangioma with propranolol[J]. J Dtsch Dermatol Ges，2010，8(3):184-186. doi: 10.1111/j.1610-0387.2009.07266.x.
18	Bonifazi E, Acquafredda A, Milano A，et al. Severe hypoglycemia during successful treatment of diffuse hemangiomatosis with propranolol[J]. Pediatr Dermatol，2010，27(2):195-196. doi: 10.1111/j.1525-1470.2009.01081.x.

[1]	王杰, 袁泉, 王玥琦, 乔佳君, 谭春丽, 夏仲元, 刘守尧. 溃疡油在糖尿病足溃疡治疗中的应用效果及安全性观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 480-484.
[2]	李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[3]	刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[4]	赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[5]	李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[6]	常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[7]	徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[8]	王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[9]	许杰, 李亚俊, 冯义文. SOX新辅助化疗后腹腔镜胃癌D2根治术与常规根治术治疗进展期胃癌的近期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 647-650.
[10]	康婵娟, 张海涛, 翟静洁. 胰管支架置入术治疗急性胆源性胰腺炎的效果及对患者肝功能、炎症因子水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 667-670.
[11]	付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[12]	刘柏隆, 周祥福. 女性尿失禁吊带手术并发症处理的经验分享[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 127-127.
[13]	嵇振岭, 陈杰, 唐健雄. 重视复杂腹壁疝手术并发症的预防和处理[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 601-606.
[14]	石阳, 于剑锋, 曹可, 翟志伟, 叶春祥, 王振军, 韩加刚. 可扩张金属支架置入联合新辅助化疗治疗完全梗阻性左半结肠癌围手术期并发症分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 464-471.
[15]	韩俊岭, 王刚, 马厉英, 连颖, 徐慧. 维生素D 联合匹维溴铵治疗腹泻型肠易激综合征患者疗效及对肠道屏障功能指标的影响研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 560-564.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Clinical efficacy and complication study of propranolol combined with local sclerotherapy in treatment of large hemangioma in children≤5 months old

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Clinical efficacy and complication study of propranolol combined with local sclerotherapy in treatment of large hemangioma in children≤5 months old